Wednesday, November 23, 2016

BRIEF-Eli Lilly and CO incoming CEO David Ricks on CNBC - Amyloid Hypothesis should be continued to be studied in reference to its Alzheimer's drug

* Eli Lilly and CO incoming CEO David Ricks on CNBC -

Amyloid Hypothesis should be continued to be studied in

reference to its Alzheimer's drug

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)